Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0C7AA
|
|||
| Former ID |
DIB012820
|
|||
| Drug Name |
Ozagrel
|
|||
| Synonyms |
Ozagrel (ophthalmic, eye disorders); Ozagrel (ophthalmic, eye disorders), Kissei/ Teika
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Xerophthalmia [ICD-11: 5B55.Y] | Phase 4 | [1] | |
| Chronic obstructive pulmonary disease [ICD-11: CA22; ICD-10: J44, J44.9] | Phase 1 | [2] | ||
| Company |
Kissei Pharmaceutical Co Ltd
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C13H12N2O2
|
|||
| Canonical SMILES |
C1=CC(=CC=C1CN2C=CN=C2)C=CC(=O)O
|
|||
| InChI |
1S/C13H12N2O2/c16-13(17)6-5-11-1-3-12(4-2-11)9-15-8-7-14-10-15/h1-8,10H,9H2,(H,16,17)/b6-5+
|
|||
| InChIKey |
SHZKQBHERIJWAO-AATRIKPKSA-N
|
|||
| CAS Number |
CAS 82571-53-7
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:92359
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00200356) Edaravone-Sodium Ozagrel Comparative Post-Marketing Study on Acute Ischemic Stroke. U.S. National Institutes of Health. | |||
| REF 2 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800028430) | |||
| REF 3 | Clinical pipeline report, company report or official report of GlaxoSmithKline (2009). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.